News from the Italian "Finanziaria 2008" and related pharmaceutical expenditure

News from the Italian "Finanziaria 2008" and related pharmaceutical expenditure

Bibliographic Details
Main Author:	Mario Eandi
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2008-03-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:	pharmacoeconomics health economics
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/209

Similar Items

Equity of access to innovative drugs and sustainability of pharmaceutical expenditure
by: Mario Eandi
Published: (2010-06-01)

Theory and practice of the Health Technology Assessment in countries with a predominant public health service
by: Mario Eandi
Published: (2009-06-01)

New rules for the generic drugs market introduced by the "Decreto Abruzzi"
by: Mario Eandi
Published: (2009-03-01)

A changing journal in a changing health care
by: Mario Eandi
Published: (2012-03-01)

The cost-effectiveness of prevention: is an ounce of prevention worth a pound of cure?
by: Steven Simoens
Published: (2012-03-01)

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis
by: Anne Kangethe, et al.
Published: (2021-08-01)

L’uso appropriato di antibiotici iniettivi a domicilio: criteri epidemiologici, clinici e farmacoeconomici
by: Mario Eandi, et al.
Published: (2005-03-01)

Measurement of Health Related Quality of Life in Malaria Patients in Indonesia using EQ-5D-5L
by: Dian Amalia Makatita, et al.
Published: (2019-07-01)

Country and regional variations in purchase prices for essential cancer medications
by: Raphael E. Cuomo, et al.
Published: (2017-08-01)

News from the 2007 financial act on pharmaceuticals
by: Mario Eandi
Published: (2006-01-01)

Implementation of Country-Wide Pharmacoeconomic Principles in Cancer Care in Developing Countries: Expert-Based Recommendations
by: Abdul Rahman Jazieh, et al.
Published: (2019-10-01)

Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India
by: Divya Mishra, et al.
Published: (2015-01-01)

PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
by: Kah Seng Lee, et al.
Published: (2020-12-01)

Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities
by: Anas Hamad, et al.
Published: (2023-11-01)

The pharmaceutical expenditure in Italy in 2009: toward regional federalism
by: Mario Eandi
Published: (2009-01-01)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019-01-01)

Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
by: İlkay BOZKURT
Published: (2018-12-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy
by: Reshetko O.V., et al.
Published: (2015-09-01)

Differences in selected medical care parameters in rheumatic disease ward patients of different ages of life
by: Piotr Pobrotyn, et al.
Published: (2016-06-01)

Methodology of pharmacoeconomic evaluation studies in Iran: a brief report
by: Sara Emamgholipour, et al.
Published: (2023-01-01)

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014
by: Mario Eandi
Published: (2014-12-01)

A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia
by: Francesc López, et al.
Published: (2021-12-01)

Regional control of pharmaceutical expenditure in the DL May 31, 2010 No 78
by: Mario Eandi
Published: (2010-03-01)

Rational and irrational factors in the dynamics of pharmaceutical expenditure and in the drug price negotiation
by: Mario Eandi
Published: (2006-09-01)

Evaluation of Transparency to Improve Good Governance in Pharmaceutical Regulatory Sector of Iran
by: Yasaman Herandi, et al.
Published: (2020-09-01)

A Review of the Pharmacist as Vaccinator
by: Willis M. Richardson, et al.
Published: (2019-07-01)

Evaluación de la calidad de las webs de centros de farmacoeconomía y economía de la salud en Internet mediante un cuestionario validado Evaluation of the quality of the websites of pharmacoeconomics and health economics centers through a validated questionnaire
by: Ana Domínguez-Castro, et al.
Published: (2004-08-01)

Optimization of pharmaceutical care for children with diseases of the upper respiratory tract in outpatient polyclinic institutions
by: T. S. Nehoda, et al.
Published: (2024-03-01)

Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
by: Milewska S, et al.
Published: (2021-09-01)

Pharmacoeconomic analysis in various nosologies
by: A. A. Svistunov, et al.
Published: (2022-12-01)

Letter to the Editor
by: Giorgio L. Colombo, et al.
Published: (2012-06-01)

Pharmacoeconomics of Bronchial Asthma
by: Ivanova Zlatina I., et al.
Published: (2019-06-01)

Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
by: V. V. Ivanov, et al.
Published: (2015-04-01)

Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China
by: LI Shunping, et al.
Published: (2022-10-01)

How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS)
by: Ana Carolina de Oliveira Gonçalves, et al.

Pharmaceutical assessment of the rationale of the application of chemotherapy schemes containing immunotherapeutic drugs in the treatment of classical Hodgkin's lymphoma
by: M. R. Matushchak, et al.
Published: (2023-06-01)

Cost-effectiveness thresholds or decision-making threshold: a novel perspective
by: Lihua Sun, et al.
Published: (2023-10-01)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018-01-01)